Ingalls Kerry D. 4
4 · Poseida Therapeutics, Inc. · Filed Nov 18, 2021
Insider Transaction Report
Form 4
Ingalls Kerry D.
Chief Operating Officer
Transactions
- Purchase
Common Stock
2021-11-17$7.00/sh+2,000$14,000→ 2,000 total
4 · Poseida Therapeutics, Inc. · Filed Nov 18, 2021
Common Stock